Derma Sciences has received the US Food and Drug Administration (FDA) 510(k) approval for its patented Medihoney Hydrogel Wound and Burn Dressing with Leptospermum (Manuka) honey.

The Hydroge, whichl is designed to treat first- and second-degree burns, in addition to various chronic and acute wounds, is available as both prescription and over-the-counter (OTC) formulations.

Derma Sciences president and CEO Edward Quilty said this proprietary dressing combines the healing properties of Manuka honey with hydrogels that provide and maintain a moist wound environment to help clean and debride necrotic tissue

"This dressing does not adhere to the wound bed and, as such, will not disturb the wound bed during dressing changes," Quilty said.